Clinical Trial Update: A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 clinical trial evaluating the efficacy, safety and pharmacokinetics of treprostinil palmitil inhalation powder…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Treprostinil Palmitil Inhalation Powder (treprostinil palmitil)

Snippet

Sponsor: Insmed Incorporated | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: COMPLETED